A New Challenging and Promising Era of Tyrosine Kinase Inhibitors
Author:
Affiliation:
1. TP Therapeutics, Inc., 6150 Lusk Boulevard, Suite B100, San Diego, California 92121, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/ml500091p
Reference7 articles.
1. The Protein Kinase Complement of the Human Genome
2. Mechanisms of drug resistance in kinases
3. Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
4. Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
5. Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC.
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library;SLAS Discovery;2023-12
2. SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis;Journal of Cancer Research and Clinical Oncology;2023-09-19
3. Recent advances in the development of dual ALK/ROS1 inhibitors for non-small cell lung cancer therapy;European Journal of Medicinal Chemistry;2023-09
4. New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFRWT and EGFRT790M Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking Study;ACS Omega;2022-02-18
5. Antineoplastic and Immunomodulating Agents (L);Ullmann's Encyclopedia of Industrial Chemistry;2022-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3